查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1375902

冠狀動脈支架市場規模、佔有率、趨勢分析報告：2023-2030 年按產品、地區和細分市場分類的趨勢

Coronary Stents Market Size, Share & Trends Analysis Report By Product (Bare Metal Stents (BMS), Drug Eluting Stents (DES), Bioresorbable Vascular Scaffold), By Region, And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 110 Pages | 商品交期: 2-10個工作天內

價格

冠狀動脈支架市場成長與趨勢：

Grand View Research 的最新報告顯示，到 2030 年，全球冠狀動脈支架市場規模預計將達到 121 億美元。

預計2023年至2030年該市場將以3.1%的年複合成長率擴張。微創手術和經皮冠狀動脈介入治療（PCI）手術的日益普及預計將在未來年度推動市場發展。例如，根據《韓國胸腔心血管外科雜誌》報道，2016年冠狀動脈疾病（CAD）的PCI比例78%，全國PCI比例96%，顯著高於世界平均。因此，隨著 CAD罹患率空前增加，這些 CAD 患者接受 PCI 的比例預計會增加，增加對有效冠狀動脈支架置放技術的需求。

技術進步和第二代藥物釋放型支架的推出進一步推動了成長。例如，雅培實驗室的 XIENCE Sierra 於 2018 年 5 月成為美國首個核准用於 CTO 的 DES。美敦力 (Medtronic) 於 2019 年初效仿，獲得 FDA核准在 CTO 適應症中使用其 Resolute 系列 DES。此外，多家公司最近在美國推出了新版本的冠狀動脈支架系統，其中最著名的是波士頓科學公司於 2021 年 1 月推出的 Synergy Megatron 以及雅培實驗室於 2021 年 6 月推出的 XIENCE Skypoint。

COVID-19大流行對冠狀動脈支架市場產生了負面影響。根據世界各地醫學協會的指導方針，手術推遲主要影響合格的患者的非緊急和選擇性手術。例如，ACC（美國心臟病學會）2020 年指南建議在 COVID-19 爆發高峰期間推遲 CTO 干涉和監測血管造影術等非緊急手術。這些指南影響著世界各地醫生的治療決策。此外，根據歐洲心臟學會的建議，所有緊急和緊急PCI手術（STEMI、高或中危NSTEMI、心源性休克、不穩定心絞痛的治療）應在疫情高峰期及之後進行。在COVID-19 捲土重來期間，應繼續進行治療，而僅應延後選擇性PCI 手術（CTO 介入或NYHA II 症狀的治療）。

此外，冠狀動脈支架市場從 COVID-19 大流行中復甦預計將得益於緊急 PCI 手術的持續執行和非選擇性手術運轉率的提高。

冠狀動脈支架市場是由一般公共機構醫療保險和醫療補助服務中心 (CMS) 和私人付款人提供的報銷保險所推動的。頸動脈置入術的保險範圍是基於國家保險範圍的確定，其中包括產品和服務提供者。從 2020 年 1 月開始，醫療保險和醫療補助服務中心 (CMS)提案對門診手術中心 (ASC) 進行的特定血管成形術和支架置入置入術進行報銷，預計將在預測期內增加市場收益。

冠狀動脈支架市場報告亮點

  • 隨著高齡化和合格PCI 條件的患者數量的增加，採用冠狀動脈支架裝置治療的 PCI 手術總數將會增加，新技術和治療嚴重病變的能力也會增加。
  • 生物可吸收血管支架可以在冠狀動脈疾病的治療中暫時放置在患者的心臟中，三年內分解以方便未來的治療，並在患者體內完全溶解，由於多種優勢，預計將成為成長第二快的領域例如：
  • 成功的臨床試驗證明 DES 優於標準 BMS。因此，DES 將在 2021 年佔據市場主導地位。
  • 北美在冠狀動脈支架市場佔據主導地位，2022 年收益佔有率最大，為 32.6%，預計在可預見的未來將繼續保持同樣的趨勢。
  • 亞太地區的冠狀動脈支架市場預計將呈現最快的成長速度。該市場受到其他變數的推動，例如增強的 CAD 篩檢、經濟成長、法規更新以及澳大利亞和韓國等一些國家的顯著優惠報銷。

目錄

第1章 調查方法和範圍

第2章 執行摘要

第3章 冠狀動脈支架變數、趨勢、範圍

  • 市場體系展望
    • 母市場展望
    • 相關/附隨市場展望
  • 普及和成長前景圖
  • 市場動態
    • 市場促進因素分析
    • 市場抑制因素分析
  • 冠狀動脈支架市場分析工具
    • 產業分析-波特五力分析
    • PESTEL分析

第4章 冠狀動脈支架：產品估算與趨勢分析

  • 冠狀動脈支架市場：要點
  • 冠狀動脈支架市場：2022 年和 2030 年趨勢和市場佔有率分析
  • 裸金屬支架（BMS）
    • 裸金屬支架
  • 藥物釋放型支架（DES）
    • 藥物釋放型支架
  • 生物可吸收血管支架
    • 2018年至2030年生物可吸收血管支架市場估計與預測

第5章 冠狀動脈支架市場：區域估計與趨勢分析

  • 區域展望
  • 按地區分類的冠狀動脈支架市場：要點
  • 北美洲
  • 歐洲
  • 亞太地區
  • 拉丁美洲
  • 中東/非洲

第6章 競爭形勢

  • 主要市場參與企業的最新趨勢和影響分析
  • 公司/競爭分類
    • Abbott
    • Medtronic
    • Boston Scientific Corporation
    • Terumo Corporation
    • B Braun Melsungen AG
    • Biotronik
    • Stentys SA
    • MicroPort Scientific Corporation
    • CR Bard, Inc.
    • Cook Medical
Product Code: GVR-1-68038-106-1

Coronary Stents Market Growth & Trends:

The global coronary stents market size is expected to reach USD 12.10 billion by 2030, according to a new report by Grand View Research, Inc.. The market is expected to expand at a CAGR of 3.1% from 2023 to 2030. Increasing adoption of minimally invasive surgeries and Percutaneous Coronary Intervention (PCI) procedures is expected to drive the market in the coming years. For instance, according to The Korean Journal of Thoracic and Cardiovascular Surgery, the proportion of PCI for Coronary Artery Disease (CAD) was 78% in 2016, and the country-specific PCI proportion was 96%, which was significantly higher than the global average. As a result, the unprecedented growth in CAD incidence, along with an increase in the proportion of PCIs done in these CAD patients, is expected to raise demand for an effective coronary stent technology.

Technological advancement and the launch of 2nd generation drug-eluting stents are further fueling the growth. For instance, Abbott Laboratories Laboratories' XIENCE Sierra became the first DES approved for CTO indications in the US in May 2018. Medtronic followed suit in early 2019, obtaining FDA approval for the use of its Resolute range of DES in CTO indications. In addition, many companies have recently launched newer versions of their coronary stent systems in the US, notably Boston Scientific's Synergy Megatron in January 2021 and Abbott Laboratories Laboratories' XIENCE Skypoint in June 2021.

The global COVID-19 pandemic has had a negative impact on the market for coronary stents. According to guidelines from physician societies throughout the world, procedure deferrals primarily impacted less urgent or elective procedures for eligible patients. ACC's ((American College of Cardiology) 2020 guidance, for instance, recommended postponing non-urgent procedures like CTO interventions and surveillance angiography during the peak of the COVID-19 pandemic. These guidelines have influenced physicians' treatment decisions throughout the world. Additionally, according to the European Society of Cardiology recommendations, all emergency and urgent PCI procedures (treatment of STEMI, high or intermediate risk NSTEMI, cardiogenic shock, and unstable angina) should be continued during the peak of the pandemic and in the subsequent resurgence of COVID-19, while only elective PCI procedures (CTO interventions or treatment of NYHA II symptoms) should be deferred.

Moreover, recovery of the coronary stent market from the COVID-19 pandemic is anticipated to be aided by the continuous performance of urgent PCI procedures and an increase in capacity utilization for performing non-elective procedures.

The coronary stent market is driven by reimbursement coverage provided by the general public Center for Medicare & Medicaid Services (CMS) and private payers. The coverage is availed under national coverage determination for carotid artery stenting, including products and service providers. From January 2020, the Centers for Medicare & Medicaid Services (CMS) proposed reimbursement for some angioplasty and stenting procedures performed in the ambulatory surgical centers (ASC), which is expected to boost the market revenue over the forecast period.

Coronary Stents Market Report Highlights:

  • Overall PCI procedure volumes treated with coronary stent devices will rise as the aging population and the PCI-eligible patient population grows, owing to new technologies and increased ability to treat severe lesions
  • The bioresorbable vascular scaffold segment is expected to be the second fastest growing segment due to its several advantages in treating coronary artery disease including temporary placement in the patient heart, ease for future treatments as it degrades over 3 years, and it dissolve completely in the patient body.
  • Favorable clinical trials have demonstrated that DES is better than standard BMS. As a result, in 2021, DES has dominated the market
  • North America dominated the coronary stents market and accounted for the largest revenue share of 32.6% in 2022 and is anticipated to witness the same trend over the foreseeable future.
  • The Asia Pacific market for coronary stents is expected to exhibit the fastest growth rate in terms of revenue generation. This market is driven by some additional variables of enhanced screening for CAD, economic growth, regulatory updates, and notable beneficial reimbursement in some countries such as Australia and South Korea.

Table of Contents

Chapter 1. Methodology & Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Product
    • 1.1.2. Regional scope
    • 1.1.3. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product outlook
    • 2.2.2. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Coronary stents Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Market Dynamics
    • 3.3.1. Market driver analysis
    • 3.3.2. Market restraint analysis
  • 3.4. Coronary Stents Market Analysis Tools
    • 3.4.1. Industry Analysis - Porter's
      • 3.4.1.1. Supplier power
      • 3.4.1.2. Buyer power
      • 3.4.1.3. Substitution threat
      • 3.4.1.4. Threat of new entrant
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Technological landscape
      • 3.4.2.3. Economic landscape

Chapter 4. Coronary stents: Product Estimates & Trend Analysis

  • 4.1. Coronary Stents Market: Key Takeaways
  • 4.2. Coronary Stents Market: Movement & Market Share Analysis, 2022 & 2030
  • 4.3. Bare Metal Stents (BMS)
    • 4.3.1. Bare Metal Stents (BMS) market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.4. Drug-Eluting Stents (DES)
    • 4.4.1. Drug-Eluting Stents (DES) market estimates and forecasts, 2018 to 2030 (USD Million)
      • 4.4.1.1. Biodegradable
      • 4.4.1.1.1. Biodegradable market estimates and forecasts, 2018 to 2030 (USD Million)
      • 4.4.1.2. Non-Biodegradable
      • 4.4.1.2.1. Non-Biodegradable market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.5. Bioresorbable Vascular Scaffold
    • 4.5.1. Bioresorbable vascular scaffold market estimates and forecast, 2018 to 2030 (USD Million)

Chapter 5. Coronary Stents Market: Regional Estimates & Trend Analysis

  • 5.1. Regional Outlook
  • 5.2. Coronary Stents Market by Region: Key Takeaways
  • 5.3. North America
    • 5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.3.2. U.S.
      • 5.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.3.3. Canada
      • 5.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 5.4. Europe
    • 5.4.1. UK
      • 5.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.4.2. Germany
      • 5.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.4.3. France
      • 5.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.4.4. Italy
      • 5.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.4.5. Spain
      • 5.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.4.6. Sweden
      • 5.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.4.7. Norway
      • 5.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.4.8. Denmark
      • 5.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 5.5. Asia Pacific
    • 5.5.1. Japan
      • 5.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.5.2. China
      • 5.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.5.3. India
      • 5.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.5.4. Australia
      • 5.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.5.5. Thailand
      • 5.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.5.6. South Korea
      • 5.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 5.6. Latin America
    • 5.6.1. Brazil
      • 5.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.6.2. Mexico
      • 5.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.6.3. Argentina
      • 5.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 5.7. MEA
    • 5.7.1. Saudi Arabia
      • 5.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.7.2. South Africa
      • 5.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.7.3. UAE
      • 5.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.7.4. Kuwait
      • 5.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)

Chapter 6. Competitive Landscape

  • 6.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 6.2. Company/Competition Categorization
    • 6.2.1. Abbott
      • 6.2.1.1. Company overview
      • 6.2.1.2. Financial performance
      • 6.2.1.3. Product benchmarking
      • 6.2.1.4. Strategic initiatives
    • 6.2.2. Medtronic
      • 6.2.2.1. Company overview
      • 6.2.2.2. Financial performance
      • 6.2.2.3. Product benchmarking
      • 6.2.2.4. Strategic initiatives
    • 6.2.3. Boston Scientific Corporation
      • 6.2.3.1. Company overview
      • 6.2.3.2. Financial performance
      • 6.2.3.3. Product benchmarking
      • 6.2.3.4. Strategic initiatives
    • 6.2.4. Terumo Corporation
      • 6.2.4.1. Company overview
      • 6.2.4.2. Financial performance
      • 6.2.4.3. Product benchmarking
      • 6.2.4.4. Strategic initiatives
    • 6.2.5. B Braun Melsungen AG
      • 6.2.5.1. Company overview
      • 6.2.5.2. Financial performance
      • 6.2.5.3. Product benchmarking
      • 6.2.5.4. Strategic initiatives
    • 6.2.6. Biotronik
      • 6.2.6.1. Company overview
      • 6.2.6.2. Financial performance
      • 6.2.6.3. Product benchmarking
      • 6.2.6.4. Strategic initiatives
    • 6.2.7. Stentys SA
      • 6.2.7.1. Company overview
      • 6.2.7.2. Financial performance
      • 6.2.7.3. Product benchmarking
      • 6.2.7.4. Strategic initiatives
    • 6.2.8. MicroPort Scientific Corporation
      • 6.2.8.1. Company overview
      • 6.2.8.2. Financial performance
      • 6.2.8.3. Product benchmarking
      • 6.2.8.4. Strategic initiatives
    • 6.2.9. C.R. Bard, Inc.
      • 6.2.9.1. Company overview
      • 6.2.9.2. Financial performance
      • 6.2.9.3. Product benchmarking
      • 6.2.9.4. Strategic initiatives
    • 6.2.10. Cook Medical
      • 6.2.10.1. Company overview
      • 6.2.10.2. Financial performance
      • 6.2.10.3. Product benchmarking
      • 6.2.10.4. Strategic initiatives

List of Tables

  • Table 1 List of Abbreviation
  • Table 2 North America coronary stents market, by product, 2018 - 2030 (USD Million)
  • Table 3 North America coronary stents market, by country, 2018 - 2030 (USD Million)
  • Table 4 U.S. coronary stents market, by product, 2018 - 2030 (USD Million)
  • Table 5 Canada coronary stents market, by product, 2018 - 2030 (USD Million)
  • Table 6 Europe coronary stents market, by product, 2018 - 2030 (USD Million)
  • Table 7 Europe coronary stents market, by country, 2018 - 2030 (USD Million)
  • Table 8 Germany coronary stents market, by product, 2018 - 2030 (USD Million)
  • Table 9 UK coronary stents market, by product, 2018 - 2030 (USD Million)
  • Table 10 France coronary stents market, by product, 2018 - 2030 (USD Million)
  • Table 11 Italy coronary stents market, by product, 2018 - 2030 (USD Million)
  • Table 12 Spain coronary stents market, by product, 2018 - 2030 (USD Million)
  • Table 13 Sweden coronary stents market, by product, 2018 - 2030 (USD Million)
  • Table 14 Norway coronary stents market, by product, 2018 - 2030 (USD Million)
  • Table 15 Denmark coronary stents market, by product, 2018 - 2030 (USD Million)
  • Table 16 Asia Pacific coronary stents market, by product, 2018 - 2030 (USD Million)
  • Table 17 Asia Pacific coronary stents market, by country, 2018 - 2030 (USD Million)
  • Table 18 Japan coronary stents market, by product, 2018 - 2030 (USD Million)
  • Table 19 China coronary stents market, by product, 2018 - 2030 (USD Million)
  • Table 20 India coronary stents market, by product, 2018 - 2030 (USD Million)
  • Table 21 Australia coronary stents market, by product, 2018 - 2030 (USD Million)
  • Table 22 Thailand coronary stents market, by product, 2018 - 2030 (USD Million)
  • Table 23 South Korea coronary stents market, by product, 2018 - 2030 (USD Million)
  • Table 24 Latin America coronary stents market, by product, 2018 - 2030 (USD Million)
  • Table 25 Latin America coronary stents market, by region, 2018 - 2030 (USD Million)
  • Table 26 Brazil coronary stents market, by product, 2018 - 2030 (USD Million)
  • Table 27 Mexico coronary stents market, by product, 2018 - 2030 (USD Million)
  • Table 28 Argentina coronary stents market, by product, 2018 - 2030 (USD Million)
  • Table 29 Middle East and Africa coronary stents market, by product, 2018 - 2030 (USD Million)
  • Table 30 Middle East and Africa coronary stents market, by country, 2018 - 2030 (USD Million)
  • Table 31 South Africa coronary stents market, by product, 2018 - 2030 (USD Million)
  • Table 32 Saudi Arabia coronary stents market, by product, 2018 - 2030 (USD Million)
  • Table 33 UAE coronary stents market, by product, 2018 - 2030 (USD Million)
  • Table 34 Kuwait coronary stents market, by product, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Coronary stents: Market outlook
  • Fig. 9 Coronary stents: Competitive insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 Industry value chain analysis
  • Fig. 14 Coronary stents market driver impact
  • Fig. 15 Coronary stents market restraint impact
  • Fig. 16 Coronary stents market strategic initiatives analysis
  • Fig. 17 Coronary stents market: Product movement analysis
  • Fig. 18 Coronary stents market: Product outlook and key takeaways
  • Fig. 19 Bare metal stents (BMS) market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 20 Drug-eluting stents (DES) market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 21 Biodegradable market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 22 Non-Biodegradable market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 23 Bioresorbable vascular scaffold market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 24 Global coronary stents market: Regional movement analysis
  • Fig. 25 Global coronary stents market: Regional outlook and key takeaways
  • Fig. 26 North America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 27 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 28 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 29 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 30 UK market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 31 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 32 France market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 34 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 37 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 China market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 India market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Middle East and Africa. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)